Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seo

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoidsE M Miloslavsky, U Specks, P A Merkel, et al.
Clinical and Experimental Rheumatology|May 29, 2015
Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohortsC Pagnoux, S Carette, N A Khalidi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2014
Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitisE M Miloslavsky, U Specks, P A Merkel, et al.
Arthritis and Rheumatism|June 12, 2013
Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitisE M Miloslavsky, U Specks, P A Merkel, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoidsE M Miloslavsky, U Specks, P A Merkel, et al.
Clinical and Experimental Rheumatology|May 29, 2015
Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohortsC Pagnoux, S Carette, N A Khalidi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2014
Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitisE M Miloslavsky, U Specks, P A Merkel, et al.
Arthritis and Rheumatism|June 12, 2013
Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitisE M Miloslavsky, U Specks, P A Merkel, et al.
Pageof 4